Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis

INTRODUCTION: GlycA is a novel inflammatory biomarker measured using nuclear magnetic resonance (NMR). Its NMR signal primarily represents glycosylated acute phase proteins. GlycA was associated with inflammation and development of cardiovascular disease in initially healthy women. We hypothesized t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ormseth, Michelle J., Chung, Cecilia P., Oeser, Annette M., Connelly, Margery A., Sokka, Tuulikki, Raggi, Paolo, Solus, Joseph F., Otvos, James D., Stein, C. Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445500/
https://www.ncbi.nlm.nih.gov/pubmed/25956924
http://dx.doi.org/10.1186/s13075-015-0646-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445500/
https://www.ncbi.nlm.nih.gov/pubmed/25956924
http://dx.doi.org/10.1186/s13075-015-0646-x

Ejemplares similares